Document is current
Any future updates will be listed below
-
Authors
Platt, James L
Salama, Rafik
Smythies, James
Choudhry, Hani
Davies, James OJ
Hughes, Jim R
Ratcliffe, Peter J
Mole, David R https://orcid.org/0000-0002-0984-300X
-
Funding
Funding for this research was provided by:
Cancer Research UK (A16016)
Ludwig Institute for Cancer Research
Higher Education Funding Council for England
Wellcome Trust (090532/Z/09/Z)
Wellcome Trust (078333/Z/05/Z)
Wellcome Trust (WT091857MA)
King Abdulaziz University of Saudi Arabia
- License Information
-
More Information
Article History
Received: 17 February 2016
Revised: 20 June 2016
Accepted: 15 July 2016
First Online: 9 August 2016
Conflict of interest
: PJR is a scientific co‐founder and holds equity in ReOx Ltd., a university spin‐out company that seeks to develop inhibitors of the HIF hydroxylases.
